Evidence map›Paper›PMID 30468562›Full record

ArticleAmerican journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics2019

Aberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality/asymmetry in schizophrenia and bipolar disorder.

Hamid M Abdolmaleky, Adam C Gower, Chen-Khuan Wong, Jiayi W Cox, Xiaoling Zhang, Arunthathi Thiagalingam, Rahim Shafa, Vadivelu Sivaraman, Jin-Rong Zhou, Sam Thiagalingam

Abstract read
In one paragraph

Article in American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Hamid M AbdolmalekyDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, Massachusetts.ORCID 0000-0002-8872-5174
Adam C GowerClinical and Translational Science Institute, Boston University School of Medicine, Boston, Massachusetts.
Chen-Khuan WongDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, Massachusetts.
Jiayi W CoxDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, Massachusetts.
Xiaoling ZhangDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, Massachusetts.
Arunthathi ThiagalingamDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, Massachusetts.
Rahim ShafaMetrowest CNS Research Center, Natick, Massachusetts.
Vadivelu SivaramanDepartment of Anesthesiology, Critical Care Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
Jin-Rong ZhouNutrition/Metabolism Laboratory, BIDMC, Harvard Medical School, Boston, Massachusetts.
Sam ThiagalingamDepartment of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, Massachusetts.ORCID 0000-0001-5211-266X
Boston University · USBeth Israel Deaconess Medical Center · USMetroWest Medical Center · USUniversity of Maryland, Baltimore · US

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
Boston University Clinical and Translational Science Award (CTSA) Program UL1UL1TR000157 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CENTER, DAVID M. · 2012 to 2013
$7.9M
Dissecting the metastasis suppressor complex to identify colon cancer biomarkersR21CA165707 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI THIAGALINGAM, SAM · 2013 to 2014
$386k
NCATS NIH HHS UL1 TR000157NCATS NIH HHS UL1 TR001430NCI NIH HHS R21 CA165707
6 · The paper itself

Abstract

Although the loss of brain laterality is one of the most consistent modalities in schizophrenia (SCZ) and bipolar disorder (BD), its molecular basis remains elusive. Our limited previous studies indicated that epigenetic modifications are key to the asymmetric transcriptomes of brain hemispheres. We used whole-genome expression microarrays to profile postmortem brain samples from subjects with SCZ, psychotic BD [BD[+]] or non-psychotic BD [BD(-)], or matched controls (10/group) and performed whole-genome DNA methylation (DNAM) profiling of the same samples (3-4/group) to identify pathways associated with SCZ or BD[+] and genes/sites susceptible to epigenetic regulation. qRT-PCR and quantitative DNAM analysis were employed to validate findings in larger sample sets (35/group). Gene Set Enrichment Analysis (GSEA) demonstrated that BMP signaling and astrocyte and cerebral cortex development are significantly (FDR q < 0.25) coordinately upregulated in both SCZ and BD[+], and glutamate signaling and TGFβ signaling are significantly coordinately upregulated in SCZ. GSEA also indicated that collagens are downregulated in right versus left brain of controls, but not in SCZ or BD[+] patients. Ingenuity Pathway Analysis predicted that TGFB2 is an upstream regulator of these genes (p = .0012). While lateralized expression of TGFB2 in controls (p = .017) is associated with a corresponding change in DNAM (p ≤ .023), lateralized expression and DNAM of TGFB2 are absent in SCZ or BD. Loss of brain laterality in SCZ and BD corresponds to aberrant epigenetic regulation of TGFB2 and changes in TGFβ signaling, indicating potential avenues for disease prevention/treatment.

Indexed as

AdultAutopsyBipolar DisorderBrainDNA MethylationEpigenesis, GeneticEpigenomeFemaleGenetic Predisposition to DiseaseHumansMaleMiddle AgedPromoter Regions, GeneticPsychotic DisordersSchizophreniaSignal TransductionTransforming Growth Factor betabrain asymmetryDNA methylationNR2E1schizophreniaTGFB2

Identifiers

PMID30468562
PMCPMC6386618
OpenAlexW2900830044

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.